Loading stock data…
$35.93+0.23 (+0.64%)
Medline Inc.
Medline Inc. in the Healthcare sector is trading at $35.73 with a market capitalization of $49.2B. Wall Street consensus targets $44.42 (26 analysts), implying a +24.3% move over the next 12 months. The stock is currently 30% below its 52-week high of $50.88, remaining 10.8% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $7.68B↑ | $7.35B↓ | $7.79B | — | — |
| Gross Profit | $2.21B↑ | $1.84B↓ | $1.91B | — | — |
| Operating Income | $395.00M↓ | $422.00M↓ | $425.00M | — | $612.00M |
| Net Income | $60.00M↓ | $129.00M↓ | $182.00M | — | — |
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and ...